EGFR and adenocarcinoma: The frequency of common EGFR mutations, specifically Exon 19 deletion and Exon 21 L858R, is high in patients with NSCLC, predominantly adenocarcinoma, particularly in individuals younger than 50 years, male smokers, and female non-smokers.